[2-(4-chlorophenoxy)ethyl]amine hydrochloride, 95.0%, 1g

Acetic acid n-butyl ester, min. 99%, for synthesis, 25 l, tinplate.

N-(2-bromophenyl)-3-oxobutanamide, 95.0%, 1g

3-AZABICYCLO[3.2.0]HEPTANE HCL, 95.0%, 500mg

2-(2,6-Dioxopiperidin-3-yl)-4-hydroxyisoindoline-1,3-dione, 95.0%, 25g

4-Bromo-2-fluorobenzothioamide, 97%, 1g

Ethyl 6-chloro-1H-indazole-3-carboxylate, 95.0%, 1g

THIAZOLO[4,5-C]PYRIDINE, 97.0%, 5g

ethyl 2-amino-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylate monohydrochloride, 50mg

1,4-Cyclohexanedimethanol, 95%, 1kg

2-(2-Furyl)-6-nitrobenzimidazole, 5g

2-(3-Hydroxy-1-phenylpropyl)-4-methylphenol, 95.0%, 250mg

(S)-5-(Benzyloxy)-2-(1,3-dioxoisoindolin-2-yl)-5-oxopentanoic acid, 95.0%, 100mg